Advertisement
Organisation › Details
Redwood Pharma AB
The firm is a pharmaceutical company focused on development of new ophthalmic therapies where there are clear and unmet clinical needs. Redwood Pharma’s lead product in development is a new eye drop designed to treat an underlying cause of chronic Dry Eye Disease in post-menopausal women. Through the IntelliGel® drug delivery platform, a technology developed for controlled release, the company creates exciting opportunities to improve existing therapies and also to develop new ones. *
Start | 2016-02-23 existent | |
Industry | RP101 (Redwood Pharma) | |
Industry 2 | IntelliGel® drug delivery system | |
Person | Vidaeus, Martin (Redwood Pharma AB 201602 CEO) | |
Region | Stockholm | |
Country | Sweden | |
Street | 100E Ringvägen 9th Floor | |
City | 11860 Stockholm | |
Tel | +46-8-559-34737 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: | ||
Record changed: 2024-02-12 |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top